InsidersTradesSigma
Browse the detailed record of transactions filed by Willwerth Christina, Directeur de la Stratégie. Director active across 1 companies, notably Flexion Therapeutics Inc. In total, 4 disclosures have been logged. Total volume traded: €43k. The latest transaction was disclosed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Christina Willwerth is the Chief Strategy Officer at Flexion Therapeutics Inc. In this role, she is responsible for developing and implementing the company's growth strategies. Willwerth plays a key role in analyzing market trends and identifying expansion opportunities. Her strategic vision helps guide Flexion Therapeutics toward new heights.